TORONTO–(BUSINESS WIRE)–Interaxon Inc. ( Muse®), a leading consumer neurotechnology and meditation company, announces the upcoming launch of their VR Standard Development Kit (SDK) alongside a new EEG headband designed to be compatible with all major VR head-mounted displays (HMDs) building off Interaxon’s second-generation EEG meditation & sleep headband, Muse S. Through this launch, Interaxon aims to support strategic partnership opportunities for innovations in brain health leveraging their award-winning biosensing technology in VR and AR applications.
With the rise of web3 and the Metaverse, Interaxon believes the integration of real-time biosensor data is expected to play a large role in the development of VR applications and experiences, marking a significant leap forward in this next phase of human computing and digital interaction. As these technologies evolve, they will have the capacity to leverage physiologic data from users to better understand, predict, and ultimately change mood, behavior, emotional and cognitive states, through delivering customized and personalized experiences.
Personalizing Digital Experiences: Biosensor Integration Into VR & The Metaverse
The integration of biosensor data from wearables into digital health experiences has provided consumers with new levels of personalized insights. Moving toward a more integrated future where personalized recommendations are unified across a variety of wellness applications, Interaxon believes web3 has the potential to create a more streamlined approach to digital health and data management for end-users that also leverages real-time biofeedback for powerful wellness interventions. The rise in telehealth services amid the pandemic, for example, presents an opportunity for biosensor data and real-time biofeedback to be utilized to transform the digital health and wellness space by improving the overall remote healthcare experience for providers and users alike.
“Soon, the broadly adopted technology and paradigms that we use to control and interact with our environment – and with each other – will dramatically change. Our interactions with the built environment, communications systems, entertainment platforms, transportation systems, social platforms, etc – will all be enhanced by technology that personalizes our experiences by sensing, analyzing, interpreting, and adapting to our arousal level, our cognitive status, and to our mood,” stated Interaxon’s Chief Scientific Officer Dr. Walter Greenleaf. “Precision analytics driven by biosensor and physiological inputs, in real-time, are a key component to providing substantially more engaging and more personalized immersive digital experiences.”
With an established bio-analytic measurement and feedback platform that can enable hardware and software developers in building VR applications and environments, Interaxon’s leading mEEG platform has the potential to play a key role in the connected wellness & fitness space, specifically in their hallmark areas of expertise such as mental performance (i.e. eSports and sports performance), as well as meditation and stress reduction.
Interaxon’s real-time access to brain and heart biosignals enables interactive applications with cognitive state metrics such as meditation, focus, hypnagogic states, brain performance, cognitive fatigue, and more. The level of opportunity into applications that use biometric data is still largely untapped and unexplored including areas such as creative flow and psychedelic states, education and training, social gaming, and more.
The Muse® VR SDK & Compatible VR Band
In preparation for strategic partnership opportunities, Interaxon has developed a new Muse® S-VR form factor specifically designed for comfortable use under all major VR HMDs that harnesses their four-channel EEG system with PPG, ECG, EMG (muscle tension), and EOG (ocular movements) biosensing capabilities which is set to launch in Q2 of this year.
The Muse® VR SDK beta is currently available on Android, iOS, Windows, Unity, and Unreal game engines. This Muse® VR SDK is designed to provide strategic partners the ability to leverage the Muse technology platform and help build a network of successful VR SDK partners and applications that drive meaningful health outcomes.
About Interaxon Inc.:
Interaxon is a late-stage venture company in the neurotechnology space, with a brain and biosensor platform of hardware and software products, a sophisticated data-cloud infrastructure, popular consumer and licensable B2B products, the largest database of brain data in the world, and an IP fortress with several fundamental granted brain, biosignal, VR and AR patents with early priority dates. Interaxon is currently completing an investment round to support converting the company’s current up-front cost model to an integrated subscription model.
Interaxon is headquartered in Toronto, Canada, and has subsidiaries in the U.S. and Ireland.
To learn more about Interaxon’s investment opportunities contact derek@interaxon.ca.
For more information about the Muse®VR SDK, Muse® VR Compatible EEG Band or Muse® devices visit www.choosemuse.com/VR.
Milestones we’re excited about:
Contacts
Hanna Thornton
muse@maxborgesagency.com
April 18th is National Exercise Day and users of all fitness levels can reap the…
All-new Adobe Express mobile app with Firefly generative AI and the power of Adobe creative…
ACT Entertainment announces that it has become the exclusive North American distributor of Green Hippo media servers…
Latest expansion brings fresh fruit and vegetables, dairy, meat, seafood, poultry, bread and more, to…
Respondents indicate that the company’s ambient AI solution is highly effective in decreasing burnout, improving…
NMI’s ISO and ISV partners gain access to an affordable, easily integrable point-of-sale device to…
